| scholarly article | Q13442814 |
| P50 | author | Sem H. Phan | Q42949411 |
| P2093 | author name string | Hong Jin | |
| Tianju Liu | |||
| Stephen W Chensue | |||
| Naozumi Hashimoto | |||
| P2860 | cites work | Regulation of telomerase activity in rat lung fibroblasts | Q77995639 |
| Application of tyramide signal amplification system to immunohistochemistry: a potent method to localize antigens that are not detectable by ordinary method | Q78032593 | ||
| Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow | Q78493584 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell | Q28188430 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Myofibroblasts and mechano-regulation of connective tissue remodelling | Q28216468 | ||
| Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 | Q29616092 | ||
| Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
| The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. | Q30681400 | ||
| NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future | Q33771408 | ||
| Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells | Q33963529 | ||
| Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells | Q34129368 | ||
| Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells | Q34148399 | ||
| The evolving concept of a stem cell: entity or function? | Q34299883 | ||
| Leukocytes expressing green fluorescent protein as novel reagents for adoptive cell transfer and bone marrow transplantation studies | Q35746139 | ||
| Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis | Q35833666 | ||
| Induction of telomerase activity in fibroblasts from bleomycin-injured lungs | Q38307885 | ||
| Pulmonary fibrosis: a cellular overreaction or a failure of communication? | Q39910045 | ||
| Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). | Q40166818 | ||
| Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function | Q40736018 | ||
| Prostaglandin E(2) inhibits fibroblast chemotaxis | Q40775240 | ||
| NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation | Q40912560 | ||
| Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study | Q41782250 | ||
| Distribution and characterization of GFP(+) donor hematogenous cells in Twitcher mice after bone marrow transplantation | Q42171652 | ||
| Limited proliferation and telomere dysfunction following telomerase inhibition in immortal murine fibroblasts | Q42816945 | ||
| Dual roles of IL-4 in lung injury and fibrosis | Q44306912 | ||
| Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium | Q45856605 | ||
| Muscle regeneration by bone marrow-derived myogenic progenitors | Q45885806 | ||
| Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. | Q46003277 | ||
| Hematopoietic competence is a rare property of neural stem cells that may depend on genetic and epigenetic alterations | Q48671033 | ||
| Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha. | Q50756212 | ||
| Blockade of secondary lymphoid tissue chemokine exacerbates Propionibacterium acnes-induced acute lung inflammation. | Q52022048 | ||
| Blockade of CD40-CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis. | Q52532821 | ||
| GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. | Q54798587 | ||
| Idiopathic Pulmonary Fibrosis | Q56804123 | ||
| Effect of erythromycin on matrix metalloproteinase-9 and cell migration | Q73591974 | ||
| Peripheral blood fibrocytes: differentiation pathway and migration to wound sites | Q73966720 | ||
| Acute graft-versus-host disease does not require alloantigen expression on host epithelium | Q74221421 | ||
| Bone marrow-derived cells as progenitors of lung alveolar epithelium | Q77363758 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| bone marrow | Q546523 | ||
| P304 | page(s) | 243-252 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Bone marrow-derived progenitor cells in pulmonary fibrosis | |
| P478 | volume | 113 |
| Q42594342 | "Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology. |
| Q41968950 | A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature |
| Q28660307 | Activated Wnt signaling induces myofibroblast differentiation of mesenchymal stem cells, contributing to pulmonary fibrosis |
| Q37707606 | Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor |
| Q41838448 | Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins |
| Q47761610 | Acute lung injury with endotoxin or NO2 does not enhance development of airway epithelium from bone marrow |
| Q57813942 | Advances in Molecular Mechanisms and Treatment of Radiation-Induced Pulmonary Fibrosis |
| Q35325160 | Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis. |
| Q37256652 | Aging and lung injury repair: a role for bone marrow derived mesenchymal stem cells |
| Q36634748 | Airway epithelial stem cells and the pathophysiology of chronic obstructive pulmonary disease |
| Q39150558 | Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial |
| Q36035053 | Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. |
| Q34882979 | Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? |
| Q37865870 | Anti-fibrogenic strategies and the regression of fibrosis |
| Q41717218 | Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity |
| Q39329326 | Antifibrotic effects of immobilized hyaluronidase in repeated bleomycin-induced lesions of the alveolar epithelium. |
| Q24611248 | Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways |
| Q24676530 | Apoptosis in the initiation, modulation and termination of the corneal wound healing response |
| Q33916989 | Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. |
| Q44688428 | Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis |
| Q24650762 | Biology of fibroblasts and myofibroblasts |
| Q33244386 | Biomechanics and wound healing in the cornea |
| Q37018469 | Bone Marrow CD11c+ Cell-Derived Amphiregulin Promotes Pulmonary Fibrosis |
| Q60482506 | Bone Marrow Stem Cell Contribution to Pulmonary Homeostasis and Disease |
| Q37155749 | Bone Marrow-Derived Cells in the Pathogenesis of Lung Fibrosis. |
| Q36855693 | Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance |
| Q36603480 | Bone marrow-derived c-kit+ cells attenuate neonatal hyperoxia-induced lung injury. |
| Q40313879 | Bone marrow-derived cells participate in stromal remodeling of the lung following acute bacterial pneumonia in mice. |
| Q35141654 | Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice |
| Q27021576 | Bone marrow-derived fibrocytes contribute to liver fibrosis |
| Q50523064 | Bone marrow-derived macrophages are associated with androgen modulated prostate regeneration. |
| Q33799560 | Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-α-induced pulmonary fibrosis |
| Q24295436 | Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis |
| Q36999500 | Bone-marrow-derived stem cells--our key to longevity? |
| Q34399563 | CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury |
| Q37394389 | CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes |
| Q34046726 | CXCL12 induces connective tissue growth factor expression in human lung fibroblasts through the Rac1/ERK, JNK, and AP-1 pathways |
| Q37344836 | CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells |
| Q64253973 | CXCR4-Overexpressing Umbilical Cord Mesenchymal Stem Cells Enhance Protection against Radiation-Induced Lung Injury |
| Q36093857 | Caveolin-1 signaling in lung fibrosis |
| Q35095019 | Cell plasticity in lung injury and repair: report from an NHLBI workshop, April 19-20, 2010 |
| Q51411418 | Cell therapy for fibrotic interstitial pulmonary disease: experimental study. |
| Q40046686 | Cell-matrix interactions in dermal repair and scarring |
| Q36250788 | Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1. |
| Q27003892 | Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis |
| Q34203939 | Cellular phenotype switching and microvesicles |
| Q36225775 | Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis |
| Q38917825 | Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes. |
| Q35138504 | Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors |
| Q37502208 | Chemokines and cardiac fibrosis. |
| Q33633032 | Chromatin-modifying agents convert fibroblasts to OCT4+ and VEGFR-2+ capillary tube-forming cells |
| Q36849123 | Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis |
| Q30426894 | Circulating progenitor cells in chronic lung disease |
| Q34407148 | Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome |
| Q42021296 | Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis |
| Q36007887 | Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency |
| Q33563719 | Corneal myofibroblast generation from bone marrow-derived cells |
| Q53180514 | Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases. |
| Q46572428 | Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice |
| Q36989934 | Current and emerging drugs for idiopathic pulmonary fibrosis |
| Q42113962 | Cytokines in chronic respiratory diseases |
| Q37077091 | Daily propranolol prevents prolonged mobilization of hematopoietic progenitor cells in a rat model of lung contusion, hemorrhagic shock, and chronic stress |
| Q36330703 | Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant. |
| Q35059996 | Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodeling |
| Q34558662 | Detection of alveolar fibrocytes in idiopathic pulmonary fibrosis and systemic sclerosis |
| Q35608869 | Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse |
| Q35056358 | Detection of transketolase in bone marrow-derived insulin-producing cells: benfotiamine enhances insulin synthesis and glucose metabolism |
| Q37594222 | Determinants of initiation and progression of idiopathic pulmonary fibrosis |
| Q50537866 | Differential contribution of dermal resident and bone marrow-derived cells to collagen production during wound healing and fibrogenesis in mice. |
| Q39353187 | Differential modulation of surfactant protein D under acute and persistent hypoxia in acute lung injury |
| Q34414241 | Dipyrimidine Amines: A Novel Class of Chemokine Receptor Type 4 Antagonists with High Specificity |
| Q36713583 | Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. |
| Q33863416 | Disturbed spermatogenesis associated with thickened lamina propria of seminiferous tubules is not caused by dedifferentiation of myofibroblasts |
| Q37276073 | Dynamics of the expression of intermediate filaments vimentin and desmin during myofibroblast differentiation after corneal injury |
| Q92478267 | Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy |
| Q37257093 | Emerging concepts in the pathogenesis of lung fibrosis |
| Q39797229 | Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis |
| Q37744240 | Endothelin in pulmonary fibrosis |
| Q42738467 | Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1 |
| Q36013643 | Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis |
| Q41780957 | Engraftment of neonatal lung fibroblasts into the normal and elastase-injured lung |
| Q33996286 | Epithelial origin of myofibroblasts during fibrosis in the lung |
| Q36427136 | Epithelial-mesenchymal interactions in pulmonary fibrosis |
| Q51445201 | Epithelial-mesenchymal transition contributes to SWCNT-induced pulmonary fibrosis. |
| Q39841793 | Erythromycin-induced CXCR4 expression on microvascular endothelial cells |
| Q43180245 | Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis |
| Q42607607 | Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis. |
| Q35781428 | Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. |
| Q35664090 | Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts |
| Q36514065 | Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. |
| Q38724313 | Exogenous induction of unphosphorylated PTEN reduces TGFβ-induced extracellular matrix expressions in lung fibroblasts |
| Q30413255 | FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis |
| Q33648682 | FIZZ2/RELM-β induction and role in pulmonary fibrosis |
| Q42082666 | Failure of bone marrow to reconstitute lung epithelium |
| Q37180285 | Fate and effects of adult bone marrow cells in lungs of normoxic and hyperoxic newborn mice |
| Q37178453 | Fibroblasts as architects of cancer pathogenesis |
| Q26998508 | Fibroblasts in fibrosis: novel roles and mediators |
| Q30435304 | Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis |
| Q37711395 | Fibrocyte localization to the airway smooth muscle is a feature of asthma |
| Q35209550 | Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection |
| Q28390280 | Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease |
| Q30426516 | Fibrocytes and the pathogenesis of diffuse parenchymal lung disease |
| Q34520214 | Fibrocytes are not an essential source of type I collagen during lung fibrosis |
| Q86369230 | Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model |
| Q51081479 | Fibrocytes from burn patients regulate the activities of fibroblasts. |
| Q83371739 | Fibrocytes in health and disease |
| Q37158258 | Fibrocytes in the Pathogenesis of Chronic Fibrotic Lung Disease. |
| Q30432829 | Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis |
| Q36690680 | Fibrocytes: emerging effector cells in chronic inflammation |
| Q33727178 | Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? |
| Q35769497 | Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. |
| Q30478686 | Following damage, the majority of bone marrow-derived airway cells express an epithelial marker |
| Q41855879 | Functional KCa3.1 K+ channels are required for human fibrocyte migration |
| Q35855118 | Gene expression profiling of familial and sporadic interstitial pneumonia |
| Q28571857 | Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular "rectifier" of growth factor signaling |
| Q33699188 | Gene targeting to the stroma of the prostate and bone |
| Q38026812 | Genesis of the myofibroblast in lung injury and fibrosis |
| Q28392538 | Genetic tools for identifying and manipulating fibroblasts in the mouse |
| Q35817381 | Hematopoietic Origin of Murine Lung Fibroblasts |
| Q21284513 | Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneity |
| Q33575009 | Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia |
| Q47778187 | Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis. |
| Q37729853 | Hepatocyte growth factor in lung repair and pulmonary fibrosis. |
| Q38088776 | Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis |
| Q55143948 | Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis. |
| Q34055945 | High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation. |
| Q40164945 | Hyaluronan regulates bone morphogenetic protein-7-dependent prevention and reversal of myofibroblast phenotype. |
| Q30498118 | Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis |
| Q36009074 | Hypoxia, leukocytes, and the pulmonary circulation |
| Q85123423 | Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELMα) Increases Lung Inflammation and Activates Pulmonary Microvascular Endothelial Cells via an IL-4–Dependent Mechanism |
| Q35087969 | Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage |
| Q39788067 | IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice |
| Q28272013 | IPF: new insight on pathogenesis and treatment |
| Q46698136 | Identification and Function of Fibrocytes in Skeletal Muscle Injury Repair and Muscular Dystrophy |
| Q30540730 | Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature |
| Q37734895 | Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis. |
| Q33510941 | Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts |
| Q36178967 | Identification of novel resident pulmonary stem cells: form and function of the lung side population |
| Q58214748 | Idiopathic Pulmonary Fibrosis Is Associated With Endothelial To Mesenchymal Transition |
| Q37788591 | Idiopathic Pulmonary Fibrosis—an Epidemiological and Pathological Review |
| Q21202895 | Idiopathic pulmonary fibrosis |
| Q36440438 | Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy |
| Q36726365 | Idiopathic pulmonary fibrosis: a decade of progress |
| Q38826634 | Immune Mechanisms in Pulmonary Fibrosis |
| Q35964652 | Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice |
| Q37220539 | In perspective: murine models of scleroderma |
| Q50770519 | In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. |
| Q33390722 | Increased Expression of Connective Tissue Growth Factor (CTGF) in Multiple Organs After Exposure of Non-Human Primates (NHP) to Lethal Doses of Radiation |
| Q42703912 | Increased toll-like receptor 9 expression is associated with the severity of paraquat-induced lung injury in mice |
| Q35087744 | Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis |
| Q38057707 | Influence of age on wound healing and fibrosis |
| Q35088560 | Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1/CXCR4 axis |
| Q40794919 | Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4 |
| Q28534937 | Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis |
| Q33942836 | Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis |
| Q103826189 | Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway |
| Q37992675 | Interplay between bone marrow and liver in the pathogenesis of hepatic fibrosis |
| Q40191474 | Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis |
| Q39593909 | Investigation of Telomerase/Telomeres system in Bone Marrow Mesenchymal Stem Cells derived from IPF and RA-UIP |
| Q33280561 | Isolation of an adult mouse lung mesenchymal progenitor cell population |
| Q37103575 | Knowns and unknowns of the alveolus |
| Q37175677 | Leukocyte-derived extracellular superoxide dismutase does not contribute to airspace EC-SOD after interstitial pulmonary injury |
| Q37144558 | Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells |
| Q36857873 | Liver fibrosis: possible involvement of EMT. |
| Q35068120 | Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor β1-induced lung fibrosis |
| Q39569560 | Loss of CCR2 signaling alters leukocyte recruitment and exacerbates γ-herpesvirus-induced pneumonitis and fibrosis following bone marrow transplantation |
| Q37681533 | Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12 |
| Q42321112 | Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling |
| Q38935618 | Lung Pericytes and Resident Fibroblasts: Busy Multitaskers. |
| Q37304394 | Lung bone marrow-derived hematopoietic progenitor cells enhance pulmonary fibrosis |
| Q37562363 | Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts. |
| Q51418425 | MEKK1, JNK, and SMAD3 mediate CXCL12-stimulated connective tissue growth factor expression in human lung fibroblasts. |
| Q35101770 | Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension |
| Q37088316 | Matrix Remodeling in Pulmonary Fibrosis and Emphysema. |
| Q37439490 | Matrix metalloproteinase and G protein coupled receptors: co-conspirators in the pathogenesis of autoimmune disease and cancer |
| Q28386047 | Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis |
| Q27006565 | Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome |
| Q37886849 | Mechanisms of cellular therapy in respiratory diseases |
| Q90002285 | Megakaryocytes participate in the occurrence of bleomycin-induced pulmonary fibrosis |
| Q91121482 | Mesenchymal Regulation of the Microvascular Niche in Chronic Lung Diseases |
| Q37729144 | Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. |
| Q38073092 | Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing |
| Q37236694 | Mesenchymal stem cells as vectors for lung disease |
| Q47123592 | Mesenchymal stem cells in idiopathic pulmonary fibrosis |
| Q42044926 | Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage |
| Q35459466 | Mesenchymal stromal cells from neonatal tracheal aspirates demonstrate a pattern of lung-specific gene expression |
| Q37191403 | Methods for studying stem cells: adult stem cells for lung repair |
| Q35083612 | Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. |
| Q101133373 | Molecular and cellular mechanisms of liver fibrosis and its regression |
| Q36237168 | Molecular and cellular mechanisms of pulmonary fibrosis |
| Q35641181 | Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition |
| Q40233552 | Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung |
| Q43080050 | Muscle fatigue: MK2 signaling and myofibroblast differentiation |
| Q37921386 | Myofibroblast differentiation and survival in fibrotic disease |
| Q27022840 | Myofibroblasts |
| Q36703915 | Neonatal hyperoxia increases sensitivity of adult mice to bleomycin-induced lung fibrosis |
| Q36821498 | New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma |
| Q36749464 | New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy. |
| Q42909477 | New light is shed on the enigmatic origin of the lung myofibroblast |
| Q30434264 | New mechanisms of pulmonary fibrosis |
| Q93368809 | New therapeutics based on emerging concepts in pulmonary fibrosis |
| Q38153815 | New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research |
| Q83709984 | Nicotinic acetylcholine receptor α7 subunit is time-dependently expressed in distinct cell types during skin wound healing in mice |
| Q37585596 | Non-invasive biomarkers in pulmonary fibrosis |
| Q35113838 | Novel interventional approaches for ALI/ARDS: cell-based gene therapy |
| Q26863633 | Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts |
| Q38243843 | Origin of myofibroblasts and cellular events triggering fibrosis |
| Q38139402 | Origins of fibrosis: pericytes take centre stage |
| Q33730722 | Overexpression of sonic Hedgehog in the lung mimics the effect of lung injury and compensatory lung growth on pulmonary Sca-1 and CD34 positive cells |
| Q46362410 | Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair |
| Q35083918 | Participation of bone marrow-derived cells in fibrotic changes in denervated skeletal muscle. |
| Q38222245 | Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications |
| Q51820680 | Pathological airway remodelling in inflammation. |
| Q35138521 | Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-/-) knockout mice |
| Q36753326 | Phenotypic transitions and fibrosis in diabetic nephropathy |
| Q37594827 | Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis |
| Q37137667 | Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. |
| Q48425946 | Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells |
| Q51919257 | Presence of human circulating progenitor cells for cancer stromal fibroblasts in the blood of lung cancer patients. |
| Q61807364 | Pretreatment with G-CSF Could Enhance the Antifibrotic Effect of BM-MSCs on Pulmonary Fibrosis |
| Q34419649 | Primary mesenchymal stem cells in human transplanted lungs are CD90/CD105 perivascularly located tissue-resident cells |
| Q34756286 | Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid |
| Q35321400 | Profibrotic potential of prominin-1+ epithelial progenitor cells in pulmonary fibrosis |
| Q27321863 | Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection |
| Q47847209 | Protection against hyperoxia-induced lung fibrosis by KGF-induced MSCs mobilization in neonatal rats. |
| Q33503888 | Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model |
| Q98770807 | Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies |
| Q27694249 | Pulmonary fibrosis: patterns and perpetrators |
| Q35852362 | Pulmonary fibrosis: thinking outside of the lung |
| Q27309062 | Pulmonary vaccination as a novel treatment for lung fibrosis |
| Q42368982 | R1R2 peptide ameliorates pulmonary fibrosis in mice through fibrocyte migration and differentiation |
| Q36298255 | Rapid detection of circulating fibrocytes by flowcytometry in idiopathic pulmonary fibrosis |
| Q38187607 | Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease |
| Q35787045 | Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. |
| Q38364228 | Regulation and Relevance of Myofibroblast Responses in Idiopathic Pulmonary Fibrosis |
| Q36539561 | Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment |
| Q42031550 | Relative Roles of TGF-β and IGFBP-5 in Idiopathic Pulmonary Fibrosis |
| Q92802221 | Remember Me? The Bone Marrow in Pulmonary Fibrosis |
| Q34212686 | Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis |
| Q35852529 | Repopulation of the irradiation damaged lung with bone marrow-derived cells |
| Q90028927 | Repressive role of stabilized hypoxia inducible factor 1α expression on transforming growth factor β-induced extracellular matrix production in lung cancer cells |
| Q51615434 | Reprint of "Dynamics of the expression of intermediate filaments vimentin and desmin during myofibroblast differentiation after corneal injury". |
| Q35070897 | Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts |
| Q36846455 | Retention of human bone marrow-derived cells in murine lungs following bleomycin-induced lung injury |
| Q42474300 | Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. |
| Q44772482 | Role of bone marrow-derived progenitor cells in the maintenance and regeneration of dental mesenchymal tissues |
| Q51720099 | Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis. |
| Q26776555 | Role of redoximiRs in fibrogenesis |
| Q37071840 | Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling. |
| Q30435472 | Role of stromal cell-derived factor-1 expression in the injured mouse auditory nerve |
| Q36013707 | Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis |
| Q58799029 | S100A4 Macrophages Are Necessary for Pulmonary Fibrosis by Activating Lung Fibroblasts |
| Q36539230 | Sequestration and homing of bone marrow-derived lineage negative progenitor cells in the lung during pneumococcal pneumonia |
| Q46087419 | Serum prolidase activity and oxidative status in patients with bronchial asthma. |
| Q35102315 | Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. |
| Q24812438 | Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis |
| Q26782820 | Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge |
| Q34582154 | Signaling pathways in the epithelial origins of pulmonary fibrosis |
| Q36634731 | Smad3 signaling involved in pulmonary fibrosis and emphysema |
| Q35788811 | Smoking and idiopathic pulmonary fibrosis |
| Q36982849 | Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2. |
| Q46380757 | Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1. |
| Q38927835 | Stem Cells in Lung Injury and Repair |
| Q34361212 | Stem cells and cell therapies for cystic fibrosis and other lung diseases |
| Q24796268 | Stem cells and repair of lung injuries |
| Q83161826 | Stem cells in lung disease, repair, and the potential for therapeutic interventions: State-of-the-art and future challenges |
| Q36883763 | Stem cells in lung repair and regeneration |
| Q38116936 | Stem cells of the adult lung: their development and role in homeostasis, regeneration, and disease |
| Q36197188 | Stem cells of the alveolar epithelium |
| Q35923079 | Stromal fibroblast-bone marrow-derived cell interactions: implications for myofibroblast development in the cornea |
| Q35813675 | Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury |
| Q27349064 | Systemic inhibition of NF-kappaB activation protects from silicosis |
| Q37414976 | TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. |
| Q46113966 | TGF-β1 Signaling and Tissue Fibrosis |
| Q38267788 | TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis |
| Q37101056 | TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis |
| Q55543508 | TRAIL-Dependent Resolution of Pulmonary Fibrosis. |
| Q39580707 | TRIP-1 regulates TGF-β1-induced epithelial-mesenchymal transition of human lung epithelial cell line A549. |
| Q35145453 | TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. |
| Q33290207 | Targeted cell replacement with bone marrow cells for airway epithelial regeneration. |
| Q36138013 | Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice. |
| Q59136382 | The Development of Serum Amyloid P as a Possible Therapeutic |
| Q90151295 | The Safe and Efficacious Use of Secretome From Fibroblasts and Adipose-derived (but not Bone Marrow-derived) Mesenchymal Stem Cells for Skin Therapeutics |
| Q36488735 | The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome |
| Q35144202 | The anti-fibrotic effects of mesenchymal stem cells on irradiated lungs via stimulating endogenous secretion of HGF and PGE2. |
| Q89769221 | The balancing act of the liver: tissue regeneration versus fibrosis |
| Q35628585 | The bone marrow leaves its scar: new concepts in pulmonary fibrosis |
| Q50704685 | The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. |
| Q36382242 | The corneal fibrosis response to epithelial-stromal injury |
| Q35723493 | The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis |
| Q53291507 | The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice. |
| Q53123793 | The effect of long-term lithium treatment of bipolar disorder on stem cells circulating in peripheral blood. |
| Q36493978 | The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond |
| Q35091707 | The in vivo fibrotic role of FIZZ1 in pulmonary fibrosis |
| Q35182082 | The long pentraxin PTX3 promotes fibrocyte differentiation |
| Q58115668 | The mechanisms and potential of stem cell therapy for penile fibrosis |
| Q24683749 | The myofibroblast: one function, multiple origins |
| Q35830790 | The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles |
| Q37800756 | The pathogenesis of idiopathic pulmonary fibrosis. |
| Q35878712 | The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation |
| Q27026037 | The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis |
| Q38132249 | The potential of cell-based therapy in lung diseases |
| Q42105688 | The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. |
| Q30443091 | The role of CXC chemokines in pulmonary fibrosis |
| Q34551617 | The role of alveolar epithelium in radiation-induced lung injury |
| Q36434149 | The role of circulating fibrocytes in fibrosis |
| Q30426900 | The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders |
| Q37415507 | The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis |
| Q30433418 | The role of fibrocytes in fibrotic diseases of the lungs and heart |
| Q47770768 | The role of periostin in lung fibrosis and airway remodeling |
| Q26997815 | The role of the myofibroblast in tumor stroma remodeling |
| Q57705955 | The role of the receptor for advanced glycation end-products in lung fibrosis |
| Q35691571 | Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice |
| Q37419817 | Thrombus resolution and vein wall injury: dependence on chemokines and leukocytes |
| Q33237943 | Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane? |
| Q37115944 | Tissue regeneration as next-generation therapy for COPD--potential applications |
| Q33895521 | Tracking the elusive fibrocyte: identification and characterization of collagen-producing hematopoietic lineage cells during murine wound healing |
| Q37137920 | Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis |
| Q37356338 | Treadmill running exercise results in the presence of numerous myofibroblasts in mouse patellar tendons |
| Q38134341 | Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease. |
| Q30496088 | Unique precursors for the mesenchymal cells involved in injury response and fibrosis |
| Q24600542 | VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche |
| Q34428964 | Very late antigen-5 facilitates stromal progenitor cell differentiation into myofibroblast |
| Q35189748 | Very small embryonic-like stem cells in adult tissues-potential implications for aging |
| Q37161680 | Very small embryonic-like stem cells: characterization, developmental origin, and biological significance |
| Q24650922 | WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis |
| Q30439833 | What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis |
| Q26850229 | What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis |
| Q79381458 | [Idiopathic pulmonary fibrosis: in search of an effective treatment] |
Search more.